






























































































Table 1．Baseline characteristics of the patients
Table 1  Baseline characteristics of the patients 
 
Variable <75 years group ≧75 years group P value 
Number of patients 85 22  
Age (range) 65 (37-74) 78 (75-80)  
Male/Female 47/38 15/7 0.27 
Pathological diagnosis    
PDAC 28 8 0.76 
bile duct cancer 31 9 0.70 
IPMN 16 3 0.57 
NET 4 1 0.97 
others 6 1 0.67 
Preoperative laboratory data    
TP (g/dl) 6.3 (±1.1) 6.3 (±1.0) 0.90 
Alb (g/dl) 3.7 (±0.7) 3.5 (±0.7) 0.45 
Lymphocyte (/μl) 1634 (±569) 1425 (±383) 0.16 
Hb (g/dl) 12.1 (±1.3) 12.5 (±1.7) 0.32 
PNI 45.9 (±7.2) 45.0 (±5.2) 0.61 
PDAC:pancreatic ductal adenocarcinoma, IPMN:intraductal papillary mucinous neoplasm 
NET:neuroendocrine tumor 
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Kaplan-Meier survival curve for 75 years of age or 
older group and younger than 75 years of age group in 
patients undergoing PD. There was no difference in five 
year survival rate between the groups.（76.4％ vs 57.3％; 
p=0.249）
Fig.2
Changes in TP, Alb, Hb, lymphocytes, and PNI are 
compared between 75 years of age or older group 
and younger than 75 years of age group.  There was 
no significant difference in any nutritional indicator 
compared at five years after PD.
 22      19          14         14         12          9 
  85         76          64         51         36         22 
Fig.1   
Kaplan-Meier survival curve for 75 years of age or older group 
and younger than 75 years of age group in patients undergoing 
PD. There was no difference in five year survival rate between 
the groups.(76.4% vs 57.3%;p=0.249)  
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Fig.2  
Changes in TP, Alb, Hb, lymphocytes, and PNI are compared between 75 
years of age or older group and younger than 75 years of age group.  
There was no significant difference in any nutritional indicator compared at 
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Changes in TP, Alb, Hb, lymphocytes, and PNI are compared between 75 
years of age or older group and younger than 75 years of age group.  
There was no significant difference in any nutritional indicator compared at 
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Table 2．Comparison of laboratory data examined on before PD and five years after PD in 
patients aged 75 years or older （n=9）．
Fig.3
Comparison of nutritional indicators examined on 1 
week and 1 month after PD in patients administered 
oral nutritional supplements. Patients administered oral 
nutritional supplements had significantly higher levels of 
TP, Alb, lymphocytes, PNI, and TTR at 1 month after 
PD.
Table 2   
Comparison of laboratory data examined on before PD and five years after 
PD in patients aged 75 yea s  older (n=9). 
 
Variable Before  After five years P value 
TP (g/dl) 6.2 (±1.1) 6.8 (±0.7) 0.07 
Alb (g/dl) 3.4 (±0.8) 3.8 (±0.5) 0.18 
Lymphocyte (/μl) 1371 (±532) 1158 (±294) 0.25 
Hb (g/dl) 12.2 (±1.7) 11.5(±1.7) 0.06 
PNI 45.5 (±5.5) 45.2 (±3.1) 0.87 
 
Fig.3 
 Comparison of nutritional indicators examined on 1 week and 1 month after PD 
in patients administered oral nutritional supplements. Patients administered 
oral nutritional supplements had significantly higher levels of TP, Alb, 
lymphocytes, PNI, and TTR at 1 month after PD.  
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Nutritional indicators after pancreaticoduodenectomy and the effect 
of perioperative administration of oral nutritional supplements
First Department of Surgery, Yamagata University Graduate School of Medical Science
Shuichiro Sugawara, Toshihiro Watanabe, Koji Tezuka, Ichiro Hirai, Wataru Kimura
Background: The objective of this study was to elucidate changes in long-term nutritional indicators 
and the effect of perioperative administration of oral nutritional supplements （ONS） on nutritional 
indicators in elderly patients undergoing pancreaticoduodenectomy （PD）.
Methods: 1. We examined 107 patients who underwent PD. Patients were divided into a group aged 
75 years and over （geriatric group, 22 patients） and a group aged 74 years and under （non-geriatric 
group, 85 patients）. Changes in total protein （TP）, albumin （Alb）, hemoglobin （Hb）, lymphocytes, 
and Onodera's prognostic nutritional index （PNI） were compared between these groups 1 and 5 
years after surgery. 
2. Eight patients who underwent PD were administered ONS （300 kcal/250 mL） from 1 week before 
surgery until 4 weeks after surgery. Levels of TP, Alb, lymphocytes, Hb, HbA1c, transthyretin （TTR）, 
retinol binding protein （RBP）, and body weight were compared at 1 week and 1 month after surgery.
Results: In the geriatric group, TP and Alb but not PNI returned to normal levels by 3 and 4 years 
after surgery, and by 5 years after surgery, there was no significant difference in any nutritional 
indicator compared to results before surgery. Patients administered ONS had significantly higher 
levels of TP, Alb, lymphocytes, PNI, and TTR at 4 weeks after surgery.
Conclusions: Nutritional indicators after PD were equivalent for geriatric and non-geriatric patients 
when viewed long-term. There is a possibility that perioperative administration of ONS improves the 
nutritional status of the patient after PD.
Key words: pancreaticoduodenectomy, elderly patients, nutritional indicators, oral nutritional 
supplements
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